Description: This presentation will review the pharmacology of apixaban in which it is appropriate to initiate apixaban loading in patients previously receiving therapeutic anticoagulation. It will also clarify recommended loading strategies when transitioning from alternative IV or oral anticoagulants. In addition, the presentation will cover current guidelines and recommendations surrounding available strategies to bridge patients requiring antiplatelet therapy from cardiac catheterization, compare and contrast available pharmacologic agents, and compare P&T Committee’s stance on cangrelor with current best practices.

Microsoft Teams Webinar link to register for the live session:  Register Here

Speakers: Gerek Simonis, PharmD, and Olivia Vlasin, PharmD, PGY-1, PGY-1 Pharmacy Residents, Advocate Aurora St. Luke’s Medical Center

Objectives: ​​ 

  1. Outline the pharmacology and mechanism of action of apixaban as a direct oral anticoagulant
  2. Identify the clinical indications for initiating apixaban inpatients already on therapeutic anticoagulation and transitions from alternative IV and oral anticoagulants
  3. Identify updated guidelines and recommendations in the setting of antiplatelet bridging post-cardiac catheterization
  4. Outline and compare available pharmacologic agents in the setting of antiplatelet bridging post-cardiac catheterization

Target Audience:​ Advocate Pharmacists, Physicians, Nurses, and other interested healthcare professionals

Disclosure:​ The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose. 

Materials: PDF icon Single Activity Flyer LIVE- Simonis and Vlasin 031226.pdfPDF icon SImonis Vlasin Slides - Audience copy.pdf

Pharmacist UAN: JA0006327-0000-26-001-L01-P

Session date: 
03/12/2026 - 12:00pm to 1:00pm CDT
Location: 
St. Luke’s Family Practice MOB3 LL and Virtual via Teams Webinar
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
    Attendance Credit
    • 1.00 Approved AMA PRA Category 1 Credit™
  • 1.00 Continuing Nursing Education (CE)
    Aurora Health Care is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 1.00 contact hours have been awarded to this activity by the Wisconsin Nursing Association. To receive contact hours, participants must attend the entire activity.
    • 1.00 APRN Pharmacotherapeutic Contact Hours
  • 1.00 Continuing Pharmacy Education (CPE)
    Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Please login or register to take this course.